Sonia V Del Rincón Selected Research

Peroxisomal Targeting Signals

1/2022

Silencing PEX26 as an unconventional mode to kill drug-resistant cancer cells and forestall drug resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sonia V Del Rincón Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 08/2013
7	Melanoma (Melanoma, Malignant) 01/2022 - 05/2015
2	Carcinogenesis 01/2022 - 11/2017
2	Lymphoma (Lymphomas) 01/2022 - 11/2017
1	Peroxisome biogenesis disorders 01/2022
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Adenocarcinoma 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Leukemia 08/2013
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2013

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2013
4	Eukaryotic Initiation Factor-4EIBA 01/2022 - 05/2015
3	Histone Deacetylase InhibitorsIBA 01/2022 - 08/2013
2	Mitogen-Activated Protein KinasesIBA 01/2022 - 06/2020
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2019
2	Vorinostat FDA Link 01/2022 - 11/2017
2	AntigensIBA 01/2021 - 01/2020
1	LigandsIBA 01/2022
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2022
1	InterferonsIBA 01/2022
1	Peroxisomal Targeting SignalsIBA 01/2022
1	CRISPR-Associated Protein 9IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	CRISPR-Cas Systems Guide RNAIBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	Chloroquine (Aralen)FDA LinkGeneric 01/2022
1	CollagenIBA 01/2022
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2022
1	Serine (L-Serine)FDA Link 01/2022
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	ChemokinesIBA 01/2022
1	Sirolimus (Rapamycin)FDA Link 01/2022
1	Acyl-CoA OxidaseIBA 01/2022
1	Lysosomal-Associated Membrane Protein 2IBA 01/2022
1	OTX015IBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	cobimetinibIBA 01/2021
1	Messenger RNA (mRNA)IBA 11/2020
1	Phosphatidylinositols (Phosphatidylinositol)IBA 06/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Polysaccharides (Glycans)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	CarbohydratesIBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2017
1	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 11/2017
1	VemurafenibIBA 05/2015

Therapy/Procedure

7	Therapeutics 01/2022 - 01/2019
4	Immunotherapy 01/2022 - 01/2019